BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26505449)

  • 21. Genetic variability of ERCC1 and ERCC2 genes involved in the nucleotide excision repair pathway influences the treatment outcome of gastric cancer.
    Zheng DL; Tang GD; Chen YN; Zhang T; Qin MB
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of ERCC2 Gene Polymorphisms with Susceptibility to Diffuse Large B-Cell Lymphoma.
    Tong Y; Xiang Y; Li B; Bao S; Zhou Y; Yuan W; Ling Y; Hao D; Zhu H; Sun Z
    Med Sci Monit; 2018 Oct; 24():7015-7022. PubMed ID: 30279407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ERCC2 gene single-nucleotide polymorphism as a prognostic factor for locally advanced head and neck carcinomas after definitive cisplatin-based radiochemotherapy.
    Guberina M; Sak A; Pöttgen C; Tinhofer-Keilholz I; Budach V; Balermpas P; Von der Grün J; Rödel CM; Gkika E; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; De-Colle C; Welz S; Linge A; Lohaus F; Baretton G; Gauler T; Baumann M; Krause M; Schuler M; Bankfalvi A; Höing B; Lang S; Stuschke M
    Pharmacogenomics J; 2021 Feb; 21(1):37-46. PubMed ID: 32546699
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Relationship between ERCC2 single nucleotide polymorphisms and male idiopathic infertility in Ningxia].
    Liu CL; Jiao HY; Ma Q; Wu X; Jia ST; Jing WH; Yang QH
    Zhonghua Nan Ke Xue; 2014 May; 20(5):419-22. PubMed ID: 24908732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ERCC polymorphisms and prognosis of patients with osteosarcoma.
    Li J; Liu S; Wang W; Zhang K; Liu Z; Zhang C; Chen S; Wu S
    Tumour Biol; 2014 Oct; 35(10):10129-36. PubMed ID: 25023406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive Value of Two Polymorphisms of ERCC2, rs13181 and rs1799793, in Clinical Outcomes of Chemotherapy in Gastric Cancer Patients: A Meta-Analysis.
    Li M; Zhao Y; Zhao E; Wang K; Lu W; Yuan L
    Dis Markers; 2018; 2018():3947626. PubMed ID: 30581498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.
    Tengström M; Mannermaa A; Kosma VM; Soini Y; Hirvonen A; Kataja V
    Acta Oncol; 2014 Jun; 53(6):769-75. PubMed ID: 24716840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Letter regarding Li JS et al. entitled "ERCC polymorphisms and prognosis of patients with osteosarcoma".
    Jian Y; Tian X; Li B; Zhou Z; Wu X
    Tumour Biol; 2015 May; 36(5):3195-6. PubMed ID: 25824708
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.
    Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS
    Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
    Hattinger CM; Casotti C; Patrizio MP; Luppi S; Fantoni L; Scotlandi K; Ibrahim T; Serra M
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.
    Biason P; Hattinger CM; Innocenti F; Talamini R; Alberghini M; Scotlandi K; Zanusso C; Serra M; Toffoli G
    Pharmacogenomics J; 2012 Dec; 12(6):476-83. PubMed ID: 21826087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome.
    Le Morvan V; Smith D; Laurand A; Brouste V; Bellott R; Soubeyran I; Mathoulin-Pelissier S; Robert J
    Pharmacogenomics; 2007 Dec; 8(12):1693-703. PubMed ID: 18085999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of ERCC2 Lys751Gln (A35931C) and CCND1 (G870A) polymorphism on outcome of advanced-stage squamous cell carcinoma of the head and neck are treatment dependent.
    Zhong S; Nukui T; Buch S; Diergaarde B; Weissfeld LA; Grandis J; Romkes M; Weissfeld JL
    Cancer Epidemiol Biomarkers Prev; 2011 Nov; 20(11):2429-37. PubMed ID: 21890746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy.
    Rumiato E; Cavallin F; Boldrin E; Cagol M; Alfieri R; Basso D; Castoro C; Ancona E; Amadori A; Ruol A; Saggioro D
    Pharmacogenet Genomics; 2013 Nov; 23(11):597-604. PubMed ID: 23962907
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic variability of DNA repair mechanisms and glutathione-S-transferase genes influences treatment outcome in osteosarcoma.
    Goričar K; Kovač V; Jazbec J; Zakotnik B; Lamovec J; Dolžan V
    Cancer Epidemiol; 2015 Apr; 39(2):182-8. PubMed ID: 25592234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study on association between ERCC2/XPD single nucleotide polymorphisms and DNA adducts damage induced by B[a]P in vitro].
    Liu Y; Yu T; Xiao S; Guan Y; Li D; Jin C; Liu Q; Yang J; Wu S; Lu X
    Wei Sheng Yan Jiu; 2013 Jan; 42(1):49-54. PubMed ID: 23596707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
    Windsor RE; Strauss SJ; Kallis C; Wood NE; Whelan JS
    Cancer; 2012 Apr; 118(7):1856-67. PubMed ID: 21887680
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in ERCC2, MSH2, and OGG1 DNA repair genes and gallbladder cancer risk in a population of Northern India.
    Srivastava K; Srivastava A; Mittal B
    Cancer; 2010 Jul; 116(13):3160-9. PubMed ID: 20564624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ERCC2 rs13181 polymorphism association with glioma susceptibility in a Chinese population.
    Gao X; Tang YJ; Zhang GF; Yu L; Qi ST
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between the ERCC2 rs13181 polymorphism and the risk of glioma: a meta-analysis.
    Jia TL; Wu HJ; Wang HB; Ma WB; Xing B
    Genet Mol Res; 2015 Oct; 14(4):12577-84. PubMed ID: 26505408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.